Evidence map›Paper›PMID 40271804›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Flexible Regulation of Optical Properties Based on Structure Size-Driven Intermolecular Interactions for Phototherapy.

Zhichao Gong, Guangbo Kang, Yu Cao, Jiachen Pan, Xuejiao Rong, Xiaobing Du, Danping Zhang, He Huang, Shuxian Meng

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhichao GongSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.ORCID https://orcid.org/0009-0002-2093-265X
Guangbo KangSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.ORCID https://orcid.org/0000-0001-5353-9788
Yu CaoCollege of Chemical Engineering, Zhejiang Province Key Laboratory of Biofuel, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.
Jiachen PanSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.
Xuejiao RongSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.
Xiaobing DuSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.
Danping ZhangSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.
He HuangSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.ORCID https://orcid.org/0000-0003-3008-4869
Shuxian MengSchool of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Tianjin Key Laboratory of Biological and Pharmaceutical Engineering, Tianjin University, Tianjin, 300350, P. R. China.ORCID https://orcid.org/0000-0002-4402-689X

Funding

National Key Research and Development Project 2024YFA0918500Tianjin Science and Technology Planning Project 23YDTPJC00300
6 · The paper itself

Abstract

The precise control of optical properties in molecular systems remains a challenge for phototherapy. Herein, the strategic combination of aggregation-caused quenching (ACQ) and aggregation-induced emission (AIE) molecule creates ACQ@AIE bimolecular systems with tunable optical properties, which are almost unattainable by single-component materials. Through systematic investigation of three ACQ@AIE bimolecular systems, it is established that molecule structure size differentials dictate their intermolecular interactions and consequent optical behaviors. Crucially, AIE molecule with a smaller structure size promotes ACQ molecule clustering to enhance the photothermal effect, while when the size becomes larger, particularly approaching that of ACQ molecule, facilitating π-π stacking and boosting the photodynamic effect. These distinct assembly modes revealed through combined experimental and theoretical analyses, enable precise regulation of photothermal versus photodynamic effects by simply regulating the structure size and ratio of ACQ and AIE molecules. Building on these mechanistic insights, the optimal molecule combination of ACQ@AIE bimolecular system is engineered into nanoparticles that exhibit mild photothermal effect, strong photodynamic effect, and excellent tumor accumulation and retention, achieving near-complete tumor eradication with minimal treatment cycles while maintaining good biosafety. This work not only elucidates the fundamental structure size-interaction-property relationships in ACQ@AIE bimolecular systems but also provides generalizable strategies for developing intelligent photo theranostic materials through controlled intermolecular interaction.

Indexed as

PhotochemotherapyPhototherapyAnimalsHumansMiceNanoparticlesacq@aie bimolecular systemflexible regulationoptical propertiesphototherapystructure size‐driven intermolecular interactions

Identifiers

PMID40271804
PMCPMC12279202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.